Drug Discovery
Insilico Medicine & 4B Technologies to advance the development of innovative small molecule therapies
Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery company, and 4B Technologies Co., Ltd. ("4B ...
August 30, 2021 | News
Kintor Pharma Collaborates with Etana to Commercialize Proxalutamide to treat Covid19
Pursuant to the Licensing Agreement, Kintor Pharma will receive from Etana upfront and milestone payments, in addition to the economic benefit relating to ...
August 26, 2021 | News
Study Confirms Viraleze Provides Protection Against SARS-CoV-2
The findings, published in the peer-reviewed journal Viruses, in a special issue titled Medical Interventions for Treatment and Prevention of SAR...
August 24, 2021 | News
Standigm Expands Global Footprints with New Office in Cambridge, UK
Founded in 2015, Standigm has proprietary technology including AI platforms encompassing novel target identification to novel compound design to generate c...
August 20, 2021 | News
Daewoong Pharma, Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics
Daewoong Pharmaceutical and Hanall Biopharma of South Korea are expanding their global open collaboration initiative by investing in Alloplex Bio...
August 20, 2021 | News
Senhwa's Silmitasertib Receives US FDA Fast Track Designation
Senhwa Biosciences, Inc., a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today ann...
August 19, 2021 | News
India's first nasal vaccine for COVID-19 receives nod for Phase 2, 3 trial
India's first nasal vaccine, developed by Bharat Biotech in collaboration with the Department of Biotechnology and its PSU, the Biotechnology Industry Rese...
August 16, 2021 | News
InnoCare Announces First Subject Dosed in Clinical Trial of ICP-332
InnoCare discovered and developed the oral drug candidate ICP-332. As a non-receptor tyrosine kinase, TYK2 is a member of the JAK kinase family, which is a...
August 16, 2021 | News
NUHS Embarks on Holomedicine Research in Singapore
To be able to literally "see inside" a patient's skull and identify the location of the tumour deep in the brain, right on the operating table, may no long...
August 13, 2021 | News
Apollomics, Inc. Doses First Patient in Phase I Clinical Trial of APL-102
The Phase I trial is designed to assess the safety, tolerability and pharmacokinetics of APL-102 delivered via an oral capsule."APL-102 is an internally di...
August 10, 2021 | News
Thermo Fisher Scientific Updates Customizable TaqMan SARS-CoV-2 Mutation Panel to Detect Delta and Lambda Variants
The panel enables laboratories to track known mutations by selecting from a menu of over 50 assays designed to screen for different variants. The TaqMan SA...
August 10, 2021 | News
Antengene & MindRank AI to jointly develop first-in-class small-molecule oncology drugs
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commerc...
August 09, 2021 | News
Novavax and SII Announce Submission to Regulatory Agencies in India, Indonesia, Philippines
Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General of India and to regulatory agencies in...
August 06, 2021 | News
Clarivate Acquires Bioinfogate
Expanding and integrating drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle, allowing customer...
August 05, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
